Your browser doesn't support javascript.
loading
Impact of extremely low-frequency electromagnetic field (100 Hz, 100 G) exposure on human glioblastoma U87 cells during Temozolomide administration.
Ahmadi-Zeidabadi, Meysam; Akbarnejad, Zeinab; Esmaeeli, Marzie; Masoumi-Ardakani, Yaser; Mohammadipoor-Ghasemabad, Lily; Eskandary, Hossein.
Afiliação
  • Ahmadi-Zeidabadi M; a Neuroscience Research Center, Institute of Neuropharmacology , Kerman University of Medical Sciences , Kerman , Iran.
  • Akbarnejad Z; b ENT and Head & Neck Research center and department, Hazrat Rasoul Hospital , The five senses Institute, Iran University of medical sciences , Tehran , Iran.
  • Esmaeeli M; a Neuroscience Research Center, Institute of Neuropharmacology , Kerman University of Medical Sciences , Kerman , Iran.
  • Masoumi-Ardakani Y; c Physiology Research Center, Institute of Basic and Clinical Physiology Science , Kerman University of Medical Sciences , Kerman , Iran.
  • Mohammadipoor-Ghasemabad L; d Students Research Committee , Kerman University of Medical Sciences , Kerman , Iran.
  • Eskandary H; a Neuroscience Research Center, Institute of Neuropharmacology , Kerman University of Medical Sciences , Kerman , Iran.
Electromagn Biol Med ; 38(3): 198-209, 2019.
Article em En | MEDLINE | ID: mdl-31179753

Texto completo: 1 Coleções: 01-internacional Contexto em Saúde: 6_ODS3_enfermedades_notrasmisibles Base de dados: MEDLINE Assunto principal: Glioblastoma / Campos Eletromagnéticos / Temozolomida / Antineoplásicos Tipo de estudo: Prognostic_studies Limite: Humans Idioma: En Revista: Electromagn Biol Med Ano de publicação: 2019 Tipo de documento: Article

Texto completo: 1 Coleções: 01-internacional Contexto em Saúde: 6_ODS3_enfermedades_notrasmisibles Base de dados: MEDLINE Assunto principal: Glioblastoma / Campos Eletromagnéticos / Temozolomida / Antineoplásicos Tipo de estudo: Prognostic_studies Limite: Humans Idioma: En Revista: Electromagn Biol Med Ano de publicação: 2019 Tipo de documento: Article